<DOC>
	<DOCNO>NCT01993238</DOCNO>
	<brief_summary>The objective study evaluate safety effectiveness procedural analgesia improvement tolerability treatment Liposonix System .</brief_summary>
	<brief_title>Evaluation Procedural Analgesia Liposonix Treatment</brief_title>
	<detailed_description />
	<criteria>Subject adult female male , 18 65 year age . Subject must weigh 120 pound . Subject must Body Mass Index ≤ 30 kg/m2 . Subject must thickness skin + subcutaneous adipose tissue anticipate treatment area ≥ 2.3 cm . Subject must able read , write , speak , understand English . Female subject pregnant , suspect pregnant , lactating Subjects diagnose coagulation disorder receive anticoagulant therapy medication dietary supplement impede coagulation platelet aggregation Subject diabetes cardiovascular disease Subject aesthetic procedure region treat within past 6 month Subject systemic skin disease skin disease area treat Subject abnormality skin soft tissue abdominal wall area treat Subject previous open laparoscopic surgery anticipate treatment area Subjects prescription counter weight reduction medication program , weight reduction procedure Subject skin superficial tissue lie flat subject supine position Subjects undergoing chronic steroid immunosuppressive therapy Subjects cardiac pacemaker implantable electrical device Subjects metal implant type area treat History cancer Subjects sensory loss dysesthesia area treat Subjects take chronic benzodiazepine opiates Subjects history severe nausea/vomiting opioid analgesic Subjects sleep apnea Subjects know allergy sensitivity study drug Subjects liver disease Subjects renal failure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>